Not yet registered on PMX
This profile is generated from public regulatory records. The company has not registered on PMX yet, and PMX has not verified it.
- Country
- Pakistan
- Region
- Asia
Regulatory licences
- DMLName on licence: RELIZON PHARMACEUTICALS
Registered products
48 products
Rel-hcq 200mg TabletHydroxychloroquine sulfate 200mg(USP Specification)200mgRelmol 500mg TabletsParacetamol 500mg( USP Specifications)500mgRelrit 50mg/200mg TabletLopinavir 200mgRitonavir 50mg(USP Specification)Relvir 300mg TabletTenofovir Disproxil fumarate 300mg eq.to Tenofovir Disproxil 245mg (USP Specification)Relvo 250mg TabletLevofloxacin (as Hemihydrate) 250mg(USP Specifications)250mgRelvo 500mg TabletLevofloxacin (as Hemihydrate) 500mg(USP Specifications)500mgRelxetine 12.5mg Controlled release TabletEach enteric, Film coated, controlled tablet contains:-Paroxetine HCl hemihydrates eq. to Paroxetine 12.5mg(USP Specifications)12.5mgRemezon 20mg CapsuleEnteric coated pellets of Omeprazole eq.to Omeprazole 20mg(USP Specification)20mgRemezon 40mg CapsuleEnteric coated pellets of Omeprazole eq.to Omeprazole 40mg(USP Specification)40mgTecazon 0.5mg TabletEntecavir (as monohydrate) 0.5mg(USP Specification)0.5mgXontrix 250mg IM InjectionCefriaxone Sodium: 250 mg;250 mgXontrix 500mg IM InjectionCefriaxone Sodium: 500 mg;500 mg